QT
KLRS

Quantbot Technologies’s Kalaris Therapeutics KLRS Stock Holding History

Quantbot Technologies’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-142
Closed -$2.46K – 1988
2024
Q1 		$2.46K Sell
142
-227
-62% -$3.7K ﹤0.01% 1494
2023
Q4 		$5.77K Buy
+369
New +$14.6K ﹤0.01% 1486
2022
Q4 		– Sell
-138
Closed -$25K – 2188
2022
Q3 		$25K Buy
+138
New +$21.5K ﹤0.01% 1333
2022
Q2 		– Sell
-102
Closed -$15K – 2212
2022
Q1 		$15K Sell
102
-9
-8% -$1.79K ﹤0.01% 1415
2021
Q4 		$32K Sell
111
-108
-49% -$50.1K ﹤0.01% 1147
2021
Q3 		$126K Buy
+219
New +$101K 0.01% 911

Other funds holding KLRS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's KLRS Position: Q2 2024 in Review

Quantbot Technologies sold out of Kalaris Therapeutics (KLRS) in Q2 2024, closing a stake of 142 shares — an estimated $2.46K sold.

Quantbot Technologies first reported a position in KLRS in Q3 2021 and held it in 6 quarters. The position peaked at $126K in Q3 2021. 71 funds tracked by Wall St. Rank hold KLRS as of Q2 2024.

  • Quantbot Technologies reported no remaining Kalaris Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 142 Kalaris Therapeutics shares in Q2 2024, an estimated $2.46K.
  • Quantbot Technologies first reported a position in Kalaris Therapeutics in Q3 2021 and held it in 6 quarters.
  • Quantbot Technologies's Kalaris Therapeutics position peaked at $126K in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.